START UPS

The company, which equips building sites with cameras and uses AI-based software to monitor construction progress via mobile devices, dominate the data centers construction market.

Scanovate and its subsidiaries develop advanced digital identification and compliance technological solutions.

A beta version of the company’s cybersecurity platform is expected by the end of 2026 and full market availability in 2027.

Anthropic’s insistence that Decart’s founders and top talents move from Tel Aviv to the US and problems in the due diligence were among the obstacles that saw the $6 billion deal collapse.

The US AI giant has backed out of the negotiations for the Israeli AI startup, “Bloomberg” reports.

Since leading Wiz's last round before it was sold, the US firm has taken steps to ensure it will catch future Israeli unicorns at earlier stages.

With the completion of the fundraise, the firm’s assets under management have grown to about $800 million.

The Israeli company has benefited in recent months from the vacuum created in the cloud security market after Google acquired Wiz.

The Israeli defense-tech company provides countries with the ability to operate, maintain and update its robotic combat systems itself.

The company aims to develop a chip capable of receiving all the data needed for a robot's operation in one place, allowing it to navigate more easily and see the production line better.

After developing a smart platform that integrates with existing WAF systems in organizations, Huskeys is now expanding the solution to a broader layer of edge security management.

Headquartered in Tel Aviv, Wonderful helps enterprises in countries that do not speak English to instal AI agents.

The investment led by Salesforce will adapt HiBob’s platform to the AI era.

The Israeli drone robotics technology company has completed its merger with US company JFB, formerly engaged in the construction industry.

In the first eight months of 2026, Israeli startups have raised $9.6 billion.

Ilya Sutskever’s startup, which has raised $7 billion and has offices in Palo Alto and Tel Aviv, could be about to unveil its mysterious AI product.

The company’s Rabbit Hole is a proprietary dataset of real-world adversarial and harmful content.

Four years after raising $51 million in one of the largest ever seed rounds in Israel, Minimus's founders have informed the employees of its closure.

LTX CEO Dr. Zeev Farbman says video will not only be used for creating films and marketing content, but also for training robots, operating avatars, and building simulations.

At-Bay operates an insurtech cybersecurity development center in Israel and markets cybersecurity and data security insurance products in the US.

The former Mossad chief has become a strategic advisor in the Japanese investment giant, bringing him closer to founder and CEO Masayoshi Son.

Decart founders Dean and Orian Leitersdorf and Moshe Shalev still own 64% of the AI startup, which Anthropic is expected to buy for $6 billion.

There is considerable synergy between Decart and Anthropic, which according to Bloomberg is about to make its first acquisition in Israel.

Wonderful, one of the fastest growing companies in Israel, held a fund raising round just three months ago. Insight Partners is again expected to be among the round's leaders.

$265 million will go to Team8’s third fund, which has already made an exit, and $100 million will be allocated to follow-on investments in existing portfolio companies.

Irregular, used by OpenAI, Anthropic and Google, has been investigating cases in which AI models accessed the Internet during supposedly closed environment testing.

One of the possible buyers is Nvidia, just a few months after it invested in the company at a valuation of $4 billion.

“Globes” charts the demise of Israeli influencer sponsorship platform StreamElements, which raised $115 million during the Covid pandemic but has now sold its assets for a small fraction of this sum.

Oligo has developed runtime security across applications, cloud workloads, and AI systems, combining deep runtime visibility with real-time protection.

The company’s solutions allow life sciences enterprises to move away from designing clinical trials based on subjective assumptions toward launching trials that have been tested, optimized, and de-risked.